Theodore C. Sica Counsel

New York
T 212.419.5841 | F 973.422.6893

Ted represents financial institutions, private equity funds, hedge funds, and corporate borrowers. He excels in complex, special-situation financing transactions such as:

  • First and second lien financings
  • Subordinated financings
  • Mezzanine structures
  • Recapitalizations
  • Workouts
  • Distressed debt purchases
  • Distressed debt sales

A Certified Public Accountant, Ted has represented agent banks in cross-border and multicurrency transactions, asset-based financings, bridge loans, and leveraged acquisition financings. His experience representing both lenders and borrowers extends across many industries, including steel, airline, energy, manufacturing, health care, media, paper and forest products, retail, media, textiles, and telecommunications.

Representative Engagements

Represented the U.S. Bank National Association as administrative agent in connection with a $180 million senior secured term loan facility to Basic Energy Services Inc.
Represented TopSpin Partners in its debt financing in connection with its acquisition of J&D Brush Co. Inc.
Represented the U.S. Bank National Association as administrative agent in connection with a $450 million senior secured term loan facility to Essar Steel Minnesota LLC.
View More...

Press Mentions

Lowenstein Sandler represented 160over90, a national branding and creative services agency, in the sale of a majority stake to Searchlight Capital Partners, L.P., a private equity firm. The terms of the transaction were not disclosed. The Lowenstein deal team included Ethan Skerry, Alex Brooks, Bryan Seelig, Brian Silikovitz, Christina Iafe, Lesley Adamo, Andrew Graw, Darren Goodman, Ted Sica, Dan Suckerman, and John Wintermute. , March 1, 2016
Lowenstein Sandler is advising Diligent Corporation, the leading provider of secure online collaboration and document sharing solutions, in its definitive agreement to be acquired by Insight Venture Partners, a leading global venture capital and private equity firm. Under the terms of the transaction, stockholders of Diligent, a New Zealand Stock Exchange listed company, will receive $US 4.90 in cash for each share of Diligent stock, a consideration which values Diligent at approximately $US 624 million, including cash. The transaction remains subject to customary closing conditions, including stockholder approval, and is expected to close in the second quarter of 2Q 2016. Diligent will be a privately-held company upon closing. The Lowenstein team included Marita Makinen, Michael Reinhardt, Victoria Rutwind, Randall Dorf, Marc Lomasky, James Gregory, Darren Goodman, Michael Walutes, Lesley Adamo, Matthew Savare, Lisa Harvey, Lowell CitronTheodore Sica and Michael Brosse. , February 14, 2016
Lowenstein Sandler represented Covis Pharma S.á.r.l and Covis Injectables S.á.r.l, global specialty pharmaceutical companies providing therapeutic solutions to patients, in their all-cash $1.2 billion sale of assets to Concordia Healthcare Corp (TSX: CXR), a diverse healthcare company focused on legacy pharmaceutical products, orphan drugs, and medical devices for the diabetic population. The acquisition closed on April 21, 2015. The Lowenstein deal team was led by Ethan A. Skerry, Robert G. MinionPeter H. Ehrenberg and also included Nicholas G. Mehler, Sam E. Khan, Jean N. Samedi, Brian Shemesh, Jack D. Sidorov, Jeffrey M. Shapiro, Hilla Shimshoni, Lowell A. Citron, Theodore C. Sica, Brian A. Silikovitz, Christina Iafe, Katie Cobb, Brandon Greenblatt and Gene Cheval. , April 21, 2015

Related Areas

Bankruptcy, Financial Reorganization & Creditors’ Rights
Debt Finance
Private Equity
Transactions & Advisory Group


Fordham University School of Law ( J.D. , 2002 ) , Member, Fordham Law Review
University of Notre Dame ( B.B.A. , 1996 ) , Accountancy, 1996

Bar Admissions

New York


  • Certified Public Accountant